Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)

NCT02525263 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped The single patient enrolled began hemodialysis treatments.

Conditions

Chronic Kidney Disease
Type 2 Diabetes

Interventions

BIOLOGICAL: Neo-Kidney Augment

Sponsor

Prokidney

Collaborators

[object Object]